Notícias Eulerpool Interpace Biosciences

Interpace Biosciences Eulerpool-AFX

Interpace Biosciences Notícias de ações

Interpace Biosciences é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Interpace Biosciences nós reunimos aqui.

• 2 de agosto ·

  Seeking Alpha
  Interpace Biosciences GAAP EPS of $0.48, revenue of $12M
• 1 de agosto ·

  Yahoo
  Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
• 29 de julho ·

  Yahoo
  Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts
• 29 de julho ·

  GlobeNewswire
  Interpace Diagnostics? Announces Undefined Extension of Medicare Coverage for PancraGEN?, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts
• 29 de julho ·

  Thefly.com
  Interpace Biosciences announces extension of Medicare coverage for PancraGEN
• 4 de junho ·

  Yahoo
  Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract
• 9 de maio ·

  Yahoo
  Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
• 9 de maio ·

  Seeking Alpha
  Interpace Biosciences GAAP EPS of -$0.11
• 7 de março ·

  Yahoo
  Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
• 7 de março ·

  Seeking Alpha
  Interpace Biosciences announces preliminary Q4 revenue of $10.3M